QUOTE AND NEWS
StreetInsider.com  Sep 30  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Akorn+%28AKRX%29+to+Acquire+Xopenex%3B+Sees+Accretion+in+FY15/9872788.html for the full story.
StreetInsider.com  Sep 29  Comment 
UPGRADES RBC Capital upgrades Akorn (Nasdaq: AKRX) from Sector Perform to Outperform with a price target of $45. Oppenheimer raises Chico's, Inc. (NYSE: CHS) from Perform to Outperform with a price target of $18. Credit Suisse moves Nike (NYSE:...
Market Intelligence Center  Sep 26  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Akorn Inc. (AKRX) that includes 8.29% downside protection. Sell one contract of the Nov. '14...
StreetInsider.com  Sep 19  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Akorn+%28AKRX%29+Needs+to+Divest+Generic+Injectable+Rifampin+ANDA+in+VersaPharm+Deal+-+FTC/9847431.html for the full story.
Benzinga  Sep 17  Comment 
This week, Akorn, Inc. (NASDAQ:AKRX) offers a great buying opportunity for a short-term swing trade. As a stock, Akorn has a bevy of favorable characteristics that make this set-up a swing-trader's dream. The stock is situated in the...
FiercePharma  Sep 12  Comment 
The threat of action from lawmakers may have put a damper on pharma's tax inversion frenzy, but it has not stopped the wave of deals that are taking American drugmakers overseas. Next up could be Illinois' Akorn, which is reportedly looking into a...
Reuters  Sep 11  Comment 
U.S. specialty drugmaker Akorn Inc is exploring a bid for Belgian drugmaker UCB SA's U.S. subsidiary, a deal that would allow the company to move its tax domicile overseas in a...
TheStreet.com  Sep 4  Comment 
Story updated at 9:50 a.m. to reflect market activity. NEW YORK (TheStreet) --aLeerink Swann raised its price target for Akorn to $40 Thursday, reiterating its "market perform" rating. Shares of Akorn gained 0.6% to $39.22 in morning...
StreetInsider.com  Aug 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Akorn+%28AKRX%29+Announces+Completion+of+VPI+Holdings+Acquisition/9743788.html for the full story.
TheStreet.com  Aug 8  Comment 
NEW YORK (TheStreet) -- A San Diego-based biopharmaceutical company is gaining international attention for an experimental Ebola treatment that just saved two lives. Mapp Biopharmaceutical is that company. Although it might sound like it employs...





You may also be interested in articles related to Akorn (AKRX):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki